Expression of sixl and six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis

Chinese Journal of Pathology

Volumn 42, Issue 7, 2013, Pages 446-450

  Wei, Qiao ^a   Yu, Wei Uei ^a   Zhao, Kuai Le ^a   Fu, Xiao Long ^a   Zhu, Zheng Fei ^a   Qin, Guang Qi ^a   Chen, Huan ^a   Zhang, Zhuan Xu ^a   Gu, Yan Zi ^a   Xiang, Jia Qing ^a   Chen, Hai Quan ^a   Du, Xiang ^a   Sun, Meng Hong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Esophageal neoplasm; Prognosis; Tissue microarray

Indexed keywords

HOMEODOMAIN PROTEIN; SIX1 PROTEIN, HUMAN; SIX4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR INVASION; TUMOR VOLUME; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HOMEODOMAIN PROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE; TRANS-ACTIVATORS; TUMOR BURDEN;

EID: 84883037596     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2013.07.004     Document Type: Article

References (14)

1. Siegel K, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin, 2012, 62(1):10-29.
2. Liu Y, Chu A, Chakroun l, et al. Cooperation between myogenic regulatory factors and SIX family transcription factors is important for myoblast differentiation. Nucleic Acids Res, 2010, 38(20):6857-6871.
3. Konishi Y, Ikeda K, Iwakura Y, et al. Sixl and Six4 promote survival of sensory neurons during early trigeminal gangliogenesis. Brain Res, 2006, 1116(1):93-102.
4. Yajima H, Motohashi N, Ono Y, et al. Six family genes control the proliferation and differentiation of muscle satellite cells. Exp Cell Res, 2010, 316(17):2932-2944.
5. Christensen KL, Patrick AN, McCoy EL, et al. The six family of homeobox genes in development and cancer. Adv Cancer Res, 2008, 101:93-126.
6. Micalizzi DS, Wang CA, Farabaugh SM, et al. Homeoprotein Sixl increases TCF-beta type I receptor and converts TCF-beta signaling from suppressive to supportive for tumor growth. Cancer Res, 2010, 70(24):10371-10380.
7. Yu Y, Khan J, Khanna C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med, 2004, 10(2):175-181.
8. Behbakht K, Qamar L, Aldridge CS, et al. Sixl overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res, 2007, 67(7):3036-3042.
9. Zheng XH, Liang PH, Guo JX, et al. Expression and clinical implications of homeobox gene Sixl in cervical cancer cell lines and cervical epithelial tissues. Int J Gynecol Cancer, 2010, 20(9):1587-1592.
10. Ono H, Imoto I, Kozaki K, et al. SIXl promotes epithelialmesenchymal transition in colorectal cancer through ZEBI activation. Oncogene, 2012, 31(47):4923-4934.
11. Reichenberger KJ, Coletta RD, Schulte AP, et al. Gene amplification is a mechanism of Sixl overexpression in breast cancer. Cancer Res, 2005, 65(7):2668-2675.
12. Ng KT, Man K, Sun CK, et al. Clinicopathological significance of homeoprotein Sixl in hepatocellular carcinoma. Br J Cancer, 2006, 95(8):1050-1055.
13. Mimae T, Okada M, Hagiyama M, et al. Upregulation of notch2 and sixl is associated with progression of early-stage lung adenocarcinoma and a more aggresshe phenotype at advanced stages. Clin Cancer Res, 2012, 18(4):945-955.
14. Sehic D, Karlsson J, Sandstedt B, et al. SIXl protein expression selectively identifies blastemal elements in Wilms tumor. Pediatr Blood Cancer, 2012, 59(1):62-68.